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Key message 
Oocyte denudation can be carried out at any time up to 5 h following oocyte retrieval 
without compromising ICSI cycle outcome. 
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Abstract 
This retrospective cohort study of 2051 consecutive fresh non-donor intracytoplasmic 
sperm injection (ICSI) cycles investigated whether time from oocyte retrieval to 
denudation, precisely measured and recorded by an operator-independent automated 
radiofrequency-based system, affected cycle outcome. ICSI cycles were divided into 
two groups: group I (denudation within <2 h of oocyte retrieval, n = 1118) and group 
II (denudation 2–5 h after oocyte retrieval, n = 933). Univariate analysis by two-
sample t-test or Mann-Whitney test was used, as appropriate. Both groups were 
comparable with regards to mean number of oocytes retrieved and fertilized normally 
after ICSI. The mean number of embryos transferred and surplus embryos 
cryopreserved at the blastocyst stage were similar. There was no significant difference 
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in fertilization, embryo implantation, pregnancy, clinical pregnancy or live birth rates 
between the groups. Analysis of group I ICSI outcome after subdivision into 
immediate (up to 30 min) and early (31–119 min) denudation showed no statistically 
significant differences between the two subgroups. In conclusion, early oocyte 
denudation within <2 h after retrieval does not appear to compromise ICSI cycle 
outcome, permitting more efficiency and flexibility in scheduling laboratory workload. 
As this was a retrospective observational study, further prospective studies are 
required to confirm the findings. 
Keywords: fertilization, ICSI, oocyte denudation, oocyte retrieval, pregnancy 
Introduction 
The use of assisted reproductive technology (ART) has been steadily increasing 
worldwide (Teoh and Maheshwari, 2014). Between 2010 and 2014, the number of 
IVF/intracytoplasmic sperm injection (ICSI) cycles performed annually increased by 
20% in the UK (HFEA, 2014) and by 27% in the USA (SART, 2014). Approximately 
two-thirds of those treatment cycles involved the use of ICSI. The increase in demand 
for ART services has placed significant pressure on IVF laboratories to operate more 
efficiently in order to manage the expanding workload. 
Prior to ICSI, oocyte denudation of the corona–cumulus–complex (CCC) must be 
performed. The CCC is comprised of cells surrounding the oocyte that undergo 
orchestrated interactions to allow oocyte pre-ovulatory maturation from the diplotene 
to the metaphase II stage (MII) (Albertini et al., 2001; Dong et al., 1996). The 
presence of the CCC has also been suggested to improve oocyte cytoplasmic 
maturation and metabolism, by stimulating gene expression (McKenzie et al., 2004) 
and reducing oxidative stress (Fatehi et al., 2005). On the other hand, the cumulus 
cells block the injecting needle and therefore interfere with the delicate oocyte 
microinjection. Moreover, because only mature oocytes that have reached the MII 
stage are suitable for ICSI, optimal optical conditions to allow assessment of the 
meiotic status of the oocyte are essential, and these become limited in the presence 
of the cumulus cells (Gardner et al., 2012). 
Earlier studies reported that optimization of oocyte nuclear and cytoplasmic maturity 
requires prolonging the duration of oocyte exposure time to the CCC by pre-
incubation prior to denudation post-retrieval. Several studies (Isiklar et al., 2004; 
Patrat et al., 2012; Rienzi et al., 1998) recommended a post-retrieval window of 
longer than 2 h prior to oocyte denudation in order to optimize ICSI outcome. 
Conversely, other studies have reported no influence of the timing of oocyte 
denudation on ICSI cycle outcome (Bancena et al., 2016; Jacobs et al., 2001; Van de 
Velde et al., 1998; Yanagida et al., 1998). 
In view of the inconsistent and equivocal evidence and conflicting results to date, this 
study sought to investigate the impact of the interval between oocyte retrieval and 
denudation on ICSI cycle outcome after accounting for important confounding 
variables in order to better inform ART laboratory practices. 
Materials and methods 
Study population 
Participants were recruited from a tertiary fertility unit at a London teaching hospital. 
The study included women who started an ICSI treatment cycle using partner or 
donor sperm, produced by ejaculation or surgical retrieval where appropriate, for 
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either male factor or unexplained infertility between 1 January 2015 and 31 October 
2016; those who started cycles for the purpose of preimplantation genetic diagnosis 
or fertility preservation and those requiring oocyte donation were excluded. 
Controlled ovarian stimulation and oocyte retrieval 
FSH injections were started at a dose of 150–450 IU daily for multi-follicular ovarian 
stimulation in either the mid-luteal long down-regulation or the short gonadotrophin-
releasing hormone (GnRH) antagonist protocol as described previously (El-Toukhy et 
al., 2016; Sunkara et al., 2007). The choice of ovarian stimulation protocol and daily 
dose of FSH injections was based on female age, ovarian reserve and previous 
response to ovarian stimulation in earlier cycles. Oocyte maturation was induced using 
250 g of recombinant human chorionic gonadotrophin (HCG) (Ovitrelle; Merck 
Serono, Darmstadt, Germany) when three or more follicles of 18 mm mean diameter 
were seen on ultrasound scan. Transvaginal ultrasound-guided retrieval of cumulus–
oocyte complexes was performed using the LOGIQ® V1 portable system (GE 
Healthcare, Milwaukee, WI, USA) strictly 36 h after the HCG injection. 
Embryo transfer and luteal phase support 
Between one and three embryos were transferred under transabdominal ultrasound 
guidance using the Voluson® 730 system (GE Healthcare) 2, 3 or 5 days after oocyte 
retrieval, depending on the number and quality of the embryos available. 
The Gardner and Schoolcraft blastocyst grading system was adopted (Gardner and 
Schoolcraft, 1999). According to this classification, a blastocyst of grade 3CC (when 
the blastocele completely fills the embryo, with very few cells in both the inner cell 
mass and the trophectoderm), was considered to be the cut-off for embryo freezing. 
Surplus blastocysts of grade 3CC or higher that showed no signs of degeneration were 
cryopreserved on day 5 or 6 after fertilization (Gardner and Schoolcraft, 1999). 
The luteal phase was supported with 400 mg progesterone pessaries (Cyclogest®; 
Actavis UK Ltd, Barnstaple, Devon, UK) twice daily commencing on the day of oocyte 
retrieval and continuing until 8 weeks’ gestation. A urine pregnancy test using a 
commercially available kit was performed 16 days after oocyte retrieval to confirm a 
pregnancy. A clinical pregnancy was defined as the detection of a fetal heartbeat 
using ultrasound performed 3–4 weeks after a positive pregnancy test. A live birth 
was defined as delivery of a live baby beyond 24 weeks’ gestation. 
Laboratory procedures 
Oocyte preparation 
The cumulus–oocyte complexes were identified in sterile plastic dishes (Falcon; 
Becton Dickinson Labware, Franklin Lakes, NJ, USA), rinsed in holding medium (HM), 
Quinn’s Advantage Medium with HEPES and 10% (v/v) human serum albumin (Origio, 
Måløv, Denmark; HM+HSA), and transferred into a four-well Nunclon dish (Thermo 
Fisher Scientific, Roskilde, Denmark) containing fertilization medium (Quinn’s 
Advantage) supplemented with 10% (v/v) human albumin solution (Origio, Måløv, 
Denmark; FM+HSA). The oocytes were incubated at 37°C in an atmosphere of 6% 
CO2 and 5% O2 balanced with nitrogen in a MINC benchtop incubator (Cook Medical, 
Bloomington, IN, USA), until the time of the denudation procedure. Oocytes were 
denuded using Cumulase® according to the manufacturer’s instructions (Origio, 
Måløv, Denmark), assessed for maturity using light microscopy and mature oocytes 
were incubated in FM+HSA as before until the time of injection. The timing of oocyte 
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denudation and sperm injection in this study was based solely on workflow and 
pragmatic considerations. 
Sperm preparation 
Ejaculated semen samples were collected at the time of oocyte retrieval by 
masturbation after 2–5 days of abstinence. After evaluation of semen parameters 
according to World Health Organization criteria (Cooper et al., 2010), samples were 
separated by buoyant density centrifugation for 20 min at 300g using a discontinuous 
two-layer gradient (45% and 95% Sil-Select, Ferti Pro NV, Beernem, Belgium). The 
pellet was collected and re-suspended in 6 ml FM+HSA and centrifuged for 10 min at 
300g. The final pellet was re-suspended in 1 ml FM+HSA and incubated at 37 C in an 
atmosphere of 6% CO2 in air until the time of ICSI. 
ICSI procedure 
All mature oocytes (MII stage) were injected with sperm, with ICSI (Abdelmassih et 
al., 1996; Nagy et al., 1995; Palermo et al., 1992; Van Steirteghem et al., 1995) 
carried out on the heated stage of an inverted-phase microscope (Diaphot, Nikon 
Corporation, Tokyo, Japan) at 400× magnification, using the Hoffman modulation 
contrast system (Modulation Optics Inc., Greenvale, NY, USA). During ICSI, sperm 
were selected and immobilized in PVP 7% solution (Origio, Måløv, Denmark), oocytes 
were placed in HM+HSA and secured using a holding pipette with the polar body at 
the 6 or 12 o’clock position and the injection pipette was inserted at the 3 o’clock 
position (Nagy et al., 1995). After ICSI, oocytes were rinsed through three 40 l 
droplets of FM+HSA before overnight group culture incubation in a single 40 l drop of 
FM+HSA under oil for tissue culture (Origio, Måløv, Denmark) in the benchtop 
incubator as before. 
Timing record 
The precise timing of all laboratory procedures was recorded by an operator-
independent automated radiofrequency-based system (RI-WitnessTM, Research 
Instruments, Falmouth, Cornwall, UK). The interval between oocyte retrieval and 
denudation was calculated as that between the time of commencement of oocyte 
retrieval and the time of the beginning of denudation. The interval between 
completion of oocyte denudation and commencement of ICSI was also recorded. 
Fertilization check 
Oocytes were assessed for fertilization 18–20 h after ICSI, with normal fertilization 
indicated by the presence of two-pronuclear (2PN) within the oocyte. Normally 
fertilized oocytes were transferred and cultured as before in 40 l drops of SAGE 1-
Step (Origio, Måløv, Denmark) overlaid with mineral oil. The day of embryo transfer 
(2, 3 or 5) was assigned according to the number of 2PN embryos and patient age 
according to the protocol of the Unit. 
Embryo assessment 
Cleavage-stage embryos were assessed on day 2 and/or day 3 after oocyte retrieval 
and scored according to the number and symmetry of blastomeres and degree of 
fragmentation (Bolton et al., 1989). For patients having embryo transfer on day 5 
after oocyte retrieval, embryos were assessed on the morning of day 5 and graded 
according to blastocoel expansion, and the quality of the trophectoderm and inner cell 
mass cells (Gardner and Schoolcraft, 1999). For all cycles, surplus blastocysts of 
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grade 3CC or higher that showed no signs of degeneration were cryopreserved on day 
5/6. 
Data collection and statistical analysis 
Because the present retrospective study did not involve either therapeutic 
interventions or change to routine ICSI protocols and used routinely collected ICSI 
cycle data, the study did not require additional approval from the institutional ethics 
committee. However, each couple gave written informed consent for the use of the 
cycle data anonymously upon entering our IVF programme and before starting an 
ICSI cycle, according to HFEA stipulation. 
Data were collected for female patient demographics, ICSI cycle characteristics, 
oocyte retrieval outcome, semen parameters, and the number of embryos that were 
considered suitable for transfer or freezing. ICSI cycles were divided into two groups 
based on whether the retrieval-denudation time was less than 2 h (group I) or 2 h 
and longer (group II) (Isiklar et al., 2004; Patrat et al., 2012; Rienzi et al., 1998). 
Group I was further subdivided into immediate denudation (within 30 min) and early 
denudation (31–119 min). 
The study outcome measures were oocyte fertilization, embryo implantation, 
pregnancy, clinical pregnancy and live birth rates. Univariate analysis of the study 
outcome measures and the associated clinical variables was performed using two-
sample t-test or Mann-Whitney test, as appropriate. A multivariate logistic regression 
analysis was used to adjust for important confounding variables, including female age, 
ICSI attempt number, duration of ovarian stimulation, number of oocytes retrieved, 
semen status, duration between oocyte denudation and sperm injection, number of 
embryos transferred and surplus embryos available for cryopreservation. StatView 
software (StatView Corporation, Berkeley, CA, USA) was used for statistical analysis. 
A P-value of <0.05 was considered as statistically significant. 
Results 
Between 1st January 2015 and 31st October 2016, data for a consecutive series of 
2051 fresh non-donor ICSI cycles were collected and included in the study. The mean 
age of women in the study was 35.6  4.4 years, with 62% aged 35 years and older. 
Fresh sperm was used for ICSI in 88% of cycles. The mean ( SD) number of oocytes 
retrieved, injected with sperm and fertilized normally per cycle was 11.2  6.7, 
9.0  5.6 and 6.2  4.4, respectively. The fertilization rate per injected oocyte was 
68%. Overall, 97% of ICSI cycles resulted in embryo transfer and the mean number 
of embryos transferred per cycle was 1.6  0.6. In 42% of cycles, surplus embryos of 
suitable quality for cryopreservation developed, with a mean 3.0  1.2 embryos 
cryopreserved per cycle. The implantation, pregnancy, clinical pregnancy and live 
birth rates per cycle were 27%, 38%, 31% and 25%, respectively. 
The interval between oocyte retrieval and denudation (retrieval-denudation time) 
varied between 12 min and 5 h (mean 120  56 min). The mean retrieval-denudation 
time was similar in cycles where a biochemical pregnancy was achieved and in 
unsuccessful cycles (121  59 min versus 119  55 min, respectively). Likewise, the 
mean interval between oocyte denudation and ICSI was similar in cycles that did and 
those that did not result in pregnancy (111  72 versus 112  69 min, respectively). 
There was no statistically significant difference in the pregnancy, clinical pregnancy 
and live birth rates in relation to the retrieval-denudation time (Figure 1). The 
likelihood of a live birth was not influenced by the retrieval-denudation time (in 
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minutes), after controlling for important confounding variables, including female age, 
ICSI attempt number, duration of ovarian stimulation (in days), number of oocytes 
retrieved, semen status (ejaculated versus surgically retrieved and fresh versus 
frozen), duration between oocyte denudation and sperm injection (in minutes), 
number of embryos transferred and achieving freezing of surplus embryos (adjusted 
odds ratio [OR] = 1.0, 95% confidence [CI], 0.99–1.002). Likewise, the duration 
between oocyte denudation and sperm injection (in minutes) did not influence the 
likelihood of a live birth after adjusting for the same variables above (adjusted OR = 
1.0, 95% CI, 0.99–1.001). 
In order to account for important confounding variables, the ICSI cycles included in 
the study were separated into two groups: early denudation (retrieval-denudation 
time up to 1 h and 59 min, n = 1118) and delayed denudation (retrieval-denudation 
time of 2–5 h, n = 933). The two groups were not significantly different in terms of 
patient demographics and ovarian stimulation characteristics including female age, 
ICSI attempt number studied, ovarian stimulation regimen, duration of FSH 
stimulation, total FSH dose and parameters of semen used for ICSI (Table 1). 
The two groups were also comparable in relation to the number of oocytes retrieved, 
injected with sperm and that fertilized normally. There were no significant differences 
between the two groups in the mean number of embryos transferred, day of embryo 
transfer, proportion of cycles where supernumerary embryos were cryopreserved, and 
the mean number of embryos cryopreserved. The oocyte fertilization, embryo 
implantation, pregnancy, clinical pregnancy and live birth rates were also similar 
between the two groups (Table 2). 
After controlling for the same important confounding variables mentioned earlier, the 
likelihood of a live birth in cycles in which the retrieval-denudation time was shorter 
than 2 h was not significantly different from that in cycles in which the retrieval-
denudation time was 2 h or longer (adjusted OR = 1.13, 95% CI, 0.91–1.39). 
The ICSI cycles in which the retrieval-denudation time was shorter than 2 h were 
further subdivided into two subgroups: immediate denudation (retrieval-denudation 
time of up to 30 min, n = 66) and early denudation (retrieval-denudation time of 31–
119 min, n = 1052). The two groups were not significantly different in terms of 
patient demographics, ovarian stimulation characteristics and ICSI cycle outcome 
(Table 3). Likewise, there was no significant difference in any of those variables 
between the immediate denudation subgroup (retrieval-denudation time of up to 
30 min, n = 66) and the delayed denudation group (retrieval-denudation time of 2–
5 h, n = 933) (data not shown). 
Discussion 
To date, this is the largest study to examine the impact of different retrieval-
denudation times on fresh non-donor ICSI cycles. The study used an operator-
independent automated system for recording the retrieval-denudation time, and the 
results showed that ICSI outcome is not influenced by a retrieval-denudation time 
ranging between 1 h and 5 h. Early oocyte denudation (within <2 h of retrieval) was 
associated with similar fertilization, implantation and pregnancy rates compared with 
delayed oocyte denudation (2–5 h after retrieval). Likewise, performing oocyte 
denudation within the first 30 min or 31–119 min of retrieval did not influence ICSI 
outcome. Markers of embryo developmental potential, including surplus blastocysts 
available for cryopreservation and embryo implantation rates, were also comparable 
between early and delayed denudation. These results are in accordance with earlier 
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but smaller studies, which reported that delaying oocyte denudation for ICSI did not 
improve cycle outcomes (Jacobs et al., 2001; Van de Velde et al., 1998; Yanagida et 
al., 2004). 
Our results are also consistent with those of a recent large study involving nearly 
4000 ICSI cycles (Barcena et al., 2016), which showed no significant relationship 
between different oocyte retrieval to denudation times and ICSI outcome. The study 
by Barcena et al. (2016) exclusively included young oocyte donors (mean age 26.9 
years) and a mixture of fresh and vitrified/warmed oocytes. The study also used 
GnRH agonist for triggering oocyte maturation, mostly used frozen sperm for ICSI and 
performed cleavage-stage embryo transfer (Barcena et al., 2016). Together, the 
current study and that by Barcena et al. (2016) indicate that the retrieval-denudation 
time does not significantly affect ICSI cycle outcome regardless of female age, cause 
of infertility (i.e. female, male or unexplained), whether own or donated oocytes were 
inseminated, triggering oocyte maturation was induced by HCG or GnRH agonist, 
fresh or frozen sperm was used for ICSI or whether cleavage-stage embryos or 
blastocysts were transferred, thus allowing the results to be more generalized and 
applicable to a wider scope of clinical practice. 
The present study contrasts with previous reports (Dozortsev et al., 2004; Ho et al., 
2003; Isiklar et al., 2004, Patrat et al., 2012; Rienzi et al., 1998), which suggested 
that a delay of more than 2 h before oocyte denudation could improve oocyte 
maturity, fertilization rate, embryo quality or ICSI outcome. However, most of those 
studies included a small sample size and recorded the steps of the ICSI procedure 
timings manually. These studies also reported conflicting results in terms of specific 
outcome measures and did not account for important confounding variables including 
patient demographics, ICSI cycle characteristics and sperm parameters. 
The strengths of this study are the large number of ICSI cycles studied, permitting 
valid comparisons of cycle outcomes within the study groups, recording of the oocyte 
retrieval-denudation time using an operator-independent automated radiofrequency-
based system, reporting of live birth outcome and accounting for important 
confounding variables. Nevertheless, it is important to highlight that this study was 
retrospective and therefore the possibility of bias due to variables not included in the 
analysis cannot be excluded. In addition, the results do not indicate whether an 
oocyte retrieval-denudation time of longer than 5 h could influence ICSI outcome. It 
has been suggested that a prolonged oocyte retrieval to denudation delay of up to 6 h 
could have a positive effect on ICSI outcomes (Falcone et al., 2008), whereas a delay 
of 11 h or longer between oocyte retrieval and completing ICSI may have a 
detrimental impact on cycle outcome (Tesarik et al., 1994; Yanagida et al., 1998). It 
is also important to note that although this study suggested that the denudation to 
ICSI time did not influence cycle outcome, this variable will need to be studied 
separately in future studies to confirm these findings. 
The rapid expansion in the use of fertility services has placed an ever-increasing 
demand on ART laboratories to schedule their workflow more efficiently and maximize 
workload output (Teoh and Maheshwari, 2014). The results of this study indicate that 
the insemination window is wider than previously suggested (Dozortsev et al., 2004). 
A delay of over 2 h between oocyte retrieval and starting the ICSI procedure could 
represent a significant challenge for the efficient scheduling of clinical and laboratory 
procedures, particularly when oocyte retrievals are carried out in the afternoon in 
busy IVF clinics. Flexibility in the window during which an ICSI procedure can be 
completed without compromising cycle outcome could facilitate extending the period 
during which oocyte retrievals could be scheduled during weekdays and on weekends, 
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hence avoiding significant prolongation of the working hours of laboratory 
practitioners. Improving laboratory scheduling efficiency could also help to reduce the 
overall cost of the ICSI cycle (Teoh and Maheshwari, 2014), thus improving IVF and 
ICSI accessibility. 
In conclusion, this study suggests that oocyte denudation within 2 h of retrieval is 
associated with a comparable ICSI cycle outcome compared with oocyte denudation 
between 2 and 5 h after retrieval. Further prospective and preferably randomized 
studies are needed to confirm this result. 
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Table 1– Patient and ICSI cycle characteristics for women in groups I (retrieval-
denudation time up to 1 h and 59 min) and II (retrieval-denudation time of 2–5 h). 
Characteristics Group I 
(n = 1118) 
Group II 
(n = 933) 
Mean age in years 
  <35 years (%) 
  35–39 years (%) 
  40–42 years (%) 
  43–45 years (%) 
35.5 (4.6) 
39 
41 
15 
5 
35.7 (4.3) 
38 
44 
14 
4 
Mean ICSI attempt number 1.5 (1.0) 1.6 (1.0) 
Sperm status (%) 
  Fresh 
  Frozen 
  Ejaculated 
  Surgically retrieved 
 
88 
12 
95 
5 
 
88 
12 
96 
4 
Mean post-preparation sperm motility  89 (20) 88 (20) 
Mean motile sperm count in final preparation 
(million/ml) 
7.4 (10.4) 7.0 (10.5) 
Ovarian stimulation protocols (%) 
  Short antagonist 
  Long agonist 
 
72 
28 
 
68 
32 
Total FSH dose (IU) 2473 (1229) 2458 (1204) 
Duration of ovarian stimulation (days) 11.1 (2.1) 11.0 (2.1) 
There were no statistically significant differences between the two groups. Data are provided as mean (SD) or as shown. 
ICSI = intracytoplasmic sperm injection. 
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Table 2 – ICSI cycle outcomes for study groups I (retrieval-denudation time up to 1 h 
and 59 min) and II (retrieval-denudation time of 2–5 h).  
Outcomes Group I 
(n = 1118) 
Group II 
(n = 933) 
Mean retrieval-denudation time, minutesa 79 (59) 169 (43) 
Mean number of oocytes retrieved 11.2 (6.7) 11.2 (6.6) 
Mean number of MII oocytes injected 9.0 (5.7) 8.9 (5.6) 
Mean number of fertilized oocytes 6.2 (4.4) 6.1 (4.3) 
Fertilization rate/oocyte retrieved (%) 55 55 
Fertilization rate/oocyte injected (%) 68 68 
Number of cycles reaching ET (%) 
  Day 2 embryo 
  Day 3 embryo 
  Day 5 embryo 
1083 (97) 
125 (12) 
258 (24) 
700 (65) 
902 (97) 
117 (13) 
213 (24) 
572 (63) 
Mean number of embryos transferred/ET 
  One embryo transferred (n, %) 
  Two embryos transferred (n, %) 
  Three embryos transferred (n, %) 
1.6 (0.64) 
485 (45) 
501 (46) 
97 (9) 
1.6 (0.62) 
395 (44) 
436 (48) 
71 (8) 
Number of cycles with surplus embryos 
cryopreserved (%) 
466 (42) 393 (42) 
Mean number of embryos cryopreserved 3 (2.3) 2.8 (2.2) 
Implantation rate (%) 27 (481/1781) 26 (384/1480) 
Pregnancy rate (%) 38 37 
Clinical pregnancy rate (%) 32 31 
Live birth rate (%) 26 24 
Data are provided as mean (SD) or as shown. 
ET = embryo transfer; ICSI = intracytoplasmic sperm injection; MII = metaphase II. 
a P < 0.0001, no other statistically significant differences between the two groups.  
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Table 3 – ICSI cycle outcomes in group I based on the oocyte retrieval-denudation 
time.  
Outcomes Denudation within 
30 min 
(n = 66) 
Denudation within 
31–119 min 
(n = 1052) 
Mean time, minutesa 24 (6) 82 (21) 
Mean age in years 35.5 (4.9) 35.5 (4.5) 
Mean ICSI cycle order 1.5 (0.68) 1.6 (0.99) 
Sperm status (%) 
  Fresh 
  Frozen 
  Ejaculated 
  Surgically retrieved 
 
85 
15 
94 
6 
 
88 
12 
95 
5 
Duration of ovarian stimulation (days) 11.1 (2.1) 11.1 (2.1) 
Mean number of oocytes retrieved 11.8 (7.6) 11.2 (6.7) 
Mean number of MII oocytes injected 9.8 (6.2) 9.0 (5.7) 
Mean number of fertilized oocytes 6.7 (5.0) 6.2 (4.4) 
Fertilization rate/oocyte retrieved (%) 57 55 
Fertilization rate/oocyte injected (%) 67 68 
Number of cycles reaching ET (%) 63 (95) 1019 (97) 
Mean number of embryos transferred/ET 1.5 (0.64) 1.6 (0.64) 
Mean number of embryos cryopreserved 2.9 (1.6) 3.0 (2.4) 
Implantation rate (%) 29 (29/100) 27 (452/1681) 
Pregnancy rate (%) 35 38 
Clinical pregnancy rate (%) 35 32 
Live birth rate (%) 27 26 
Data are provided as mean (SD) or as shown. 
ET = embryo transfer; ICSI = intracytoplasmic sperm injection; MII = metaphase II. 
a P < 0.0001, no other statistically significant differences between the two groups.  
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